+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

COVID-19 Pandemic Mitigation Products Market - 2020-2024

  • ID: 5116547
  • Report
  • June 2020
  • Region: Global
  • 1020 Pages
  • Homeland Security Research Corporation
1 of 4

FEATURED COMPANIES

  • 3M Company
  • Bullard
  • Freenome
  • Intel Corporation
  • MedWhat
  • pulseData
  • MORE

According to the COVID-19 Pandemic Mitigation Products Market – 2020-2024 report scenarios, the 2020-2024 cumulative market size is expected to be $1.4-$1.9 Trillion. The U.S. and Chinese markets will dominate the global one during the forecast period.

This 1020-page 5-volume market report is the first and most comprehensive review of the global COVID-19 Pandemic Mitigation Products & Services market available today. The objective of this report is to provide today’s strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market.

The COVID-19 Pandemic Mitigation Products Market – 2020-2024 report presents a thorough market analysis of 54 products & services, 6 vertical, 4 revenue source, 5 regional and 13 national markets. Furthermore, the report provides updated extensive data of 37 key vendors.

As countries start to re-open, and you do your best to recover your business, the report brings to your attention multi-billion business opportunities that may assist your struggle to retain business continuity and growth. This newly formed market is not limited to the healthcare supplier’s industry; many business opportunities are being created for industries from geo-surveillance to blockchain, from AI, big-data & deep learning to nonwoven fabrics.

Why Buy Market Report?

A. Questions answered in this report include:

  • What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecasted trends during 2020-2024?
  • What are the most attractive business opportunities?
  • What drives the customers to purchase solutions and services?
  • What are the COVID-19 Mitigation technology & services trends?
  • What is the 212 sub-markets size over the 2020-2024 period?
  • What are the challenges to market penetration & growth?

B. The COVID-19 Pandemic Mitigation Products Market size data is analyzed via 5 independent key perspectives.

With a highly fragmented market the publisher addresses the “money trail” – each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

By 54 Products and Services:

  • Vaccines
  • Therapeutic Drugs
  • Other COVID-19 Pharma Industry Products
  • PCR Instrumentation & Software
  • Robotic PCR Systems & Software
  • PCR Reagents & Consumables
  • Nose & Mouth Swabs
  • Self-collection PCR Test Kits
  • Serologic Test Kits
  • Standoff Thermometry
  • X-Ray Procedures
  • CT Procedures
  • Ultrasound Procedures
  • FDG-PET/CT Procedures & Wastewater Testing
  • PACS & Teleradiology
  • Medical PPE Gowns
  • Medical Gloves
  • Medical  Face Masks
  • Medical Face Shields
  • Medical Eye Protection
  • PPE Sterilization: Systems & Consumables
  • Hand & Surface Sanitizers
  • Decontamination
  • Other Personal Protection Gear
  • AI, Big Data & Deep Learning
  • Homecare IT
  • Geo-Surveillance Systems & Services
  • E-Health
  • Blockchain Technologies
  • Other ICT
  • Noninvasive Ventilators
  • Invasive Mechanical Ventilators
  • Next Generation Ventilators
  • COVID-19 Homecare (HW, SW, Services)
  • Portable Ventilators
  • Surge Capacity Hospitals & ICUs
  • Kidney Dialysis
  • Extracorporeal Membrane Oxygenation Procedures
  • Other Intensive Care Modalities
  • PPE Gowns Manufacturing Plants
  • Gloves Manufacturing Plants
  • Face Masks Manufacturing Plants
  • Face Shields Manufacturing Plants
  • Sorologic Test Kits Manufacturing Plants
  • Melt-Blown PPE Fabric Manufacturing Plants
  • Spun-Bond PPE Fabric Manufacturing Plants
  • Self-collection PCR Test Kits Manufacturing Plants
  • Ventilators Manufacturing Plants
  • PCR Reagents Manufacturing Plants
  • PCR Systems Manufacturing Plants
  • Nose & Mouth Swabs Manufacturing Plants
  • Medical Glass & Other Manufacturing Plants
  • R&D Equipment & Consumables
  • Medical Glass and Other Products & Services

By 6 Vertical Market:

  • Hospitals and Surge Hospitals
  • Clinical Labs
  • Clinics
  • Emergency Medical Services (EMS)
  • Homecare & Nursing Homes
  • Research Bodies

By 13 National Markets:

  • U.S.A
  • Canada
  • UK
  • Germany
  • France
  • Italy
  • Rest of Europe
  • India
  • China
  • South Korea
  • Japan
  • Rest of Asia Pacific
  • RoW

By 5 Regional Markets:

  • North America
  • Latin America
  • Europe
  • Middle East & Africa
  • Asia Pacific

By 4 Revenue Source Markets:

  • Product Sales
  • Training Services
  • Planning & Consulting
  • Maintenance & Upgrades

C. Detailed market analysis frameworks for each of the market sectors are provided, including:

  • Market drivers & inhibitors
  • Business opportunities
  • SWOT analysis

Competitive analysis for each of the 54 products and services that covers:

  • Barriers to Entry
  • Supplier Power
  • Buyer Power
  • Barriers to Substitution.
  • Business environment
  • The 2020-2024 market segmented into 212 submarkets

D. The report provides an updated extensive data of the leading 37 companies (including companies’ profile, recent annual revenues, COVID-19 mitigation activities & products and contact information).

E. The report includes over 2300 links to the COVID-19 Pandemic Mitigation community information sources

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company
  • Bullard
  • Freenome
  • Intel Corporation
  • MedWhat
  • pulseData
  • MORE

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 1

1 Market Definition
1.1 Introduction
1.2 Scenario A: Assumptions.
1.3 Scenario B: Assumptions.

2 Executive Summary.
2.1 Key Findings
2.2 COVID-19 Mitigation Funding (January – May 2020)
2.3 Key Conclusions
2.4 COVID-19 Pandemic Mitigation Products Market Research Vectors
2.5 COVID-19 Pandemic Mitigation R&D Challenges
2.6 Global COVID-19 Pandemic Mitigation Market – 2020-2024
2.6.1 Products & Services Groups Markets
2.6.2 Products & Services Markets
2.6.3 Vertical Markets.
2.6.4 Revenue Source Markets
2.6.5 Regional Markets
2.6.6 National Markets

3 The SARS‑CoV‑2 2019 Pandemic.
3.1 COVID-19 Basics
3.2 COVID-19 Infection Rate
3.3 Social Distancing
3.4 The Effect of Quarantine
3.5 Comparison of SARS-CoV-2 and Common Cold and Flu Viruses.
3.6 The SARS-CoV-2 Genome Information
3.7 Active Infection Testing
3.7.1 Nucleic Acid Detection
3.7.2 Antigen Detection.
3.7.3 Other Technologies
3.8 Serology Testing

4 Market Drivers

5 Market Inhibitors

6 COVID-19 Pandemic Mitigation Products Market SWOT Analysis
6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats

7 Business Opportunities & Challenges

8 COVID-19 Pandemic Mitigation Industry
8.1 The COVID-19 Pandemic Mitigation Products Value Chain.
8.2 COVID-19 Pandemic Mitigation Products Industry Primary Activities.
8.3 COVID-19 Pandemic Mitigation Products industry Support Activities.

9 COVID-19 Pandemic Mitigation Products Industry: Barriers to Entry, Supplier Power, Buyer Power & Barriers to Substitution.

10 Global COVID-19 Pandemic Mitigation Market – 2020-2024
10.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets – 2020-2024
10.1.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario A.
10.1.1.1 Market Size
10.1.1.2 Market Dynamics
10.1.1.3 Market Share
10.1.2 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario B.
10.1.2.1 Market Size
10.1.2.2 Market Dynamics
10.1.2.3 Market Share
10.1.3 Global COVID-19 Pandemic Mitigation Market: Scenarios Comparison.
10.2 Global COVID-19 Pandemic Mitigation Products & Services Markets – 2020-2024
10.2.1 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario A.
10.2.1.1 Market Size
10.2.1.2 Market Dynamics
10.2.2 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario B.
10.2.2.1 Market Size
10.2.2.2 Market Dynamics.
10.2.3 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenarios Comparison
10.3 Global Vertical COVID-19 Pandemic Mitigation Markets – 2020-2024.
10.3.1 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario A
10.3.1.1 Market Size
10.3.1.2 Market Dynamics.
10.3.1.3 Market Share.
10.3.2 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario B
10.3.2.1 Market Size
10.3.2.2 Market Dynamics.
10.3.2.3 Market Share.
10.3.3 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenarios Comparison
10.4 Global COVID-19 Pandemic Mitigation Products & Services Market by Revenue Source – 2020-2024
10.4.1 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario A.
10.4.2 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario B.
10.4.3 Global COVID-19 Pandemic Mitigation Revenue Sources: Scenarios Comparison.
10.5 Regional COVID-19 Pandemic Mitigation Markets – 2020-2024
10.5.1 Regional COVID-19 Pandemic Mitigation Market: Scenario A.
10.5.1.1 Market Size
10.5.1.2 Market Dynamics.
10.5.1.3 Market Share.
10.5.2 Regional COVID-19 Pandemic Mitigation Market: Scenario B.
10.5.2.1 Market Size
10.5.2.2 Market Dynamics.
10.5.2.3 Market Share.
10.5.3 Regional COVID-19 Pandemic Mitigation Market: Scenarios Comparison
10.6 National COVID-19 Pandemic Mitigation Markets – 2020-2024
10.6.1 National COVID-19 Pandemic Mitigation Market: Scenario A.
10.6.1.1 Market Size
10.6.1.2 Market Dynamics.
10.6.1.3 Market Shares
10.6.2 National COVID-19 Pandemic Mitigation Market: Scenario B.
10.6.2.1 Market Size
10.6.2.2 Market Dynamics.
10.6.2.3 Market Share.
10.6.3 COVID-19 National Markets: Scenarios Comparison.

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 2

1 COVID-19 Vaccines Market – 2020-2024
1.1 COVID-19 Vaccines Market Background
1.1.1 Introduction
1.1.2 Global COVID-19 Vaccine Development Funding.
1.1.3 Vaccines Prices.
1.1.4 COVID-19 Vaccines Market: Conclusions.
1.1.5 COVID-19 Vaccines:Business Opportunities
1.1.6 COVID-19 Vaccines: Competitive Analysis: : Barriers to Entry, Supplier Power, Buyer Power and Substitution
1.1.7 Present and Potential Vendors.
1.2 Global COVID-19 Pandemic Mitigation: Vaccines Market – 2020-2024.
1.2.1 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
1.2.2 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

2 COVID-19 Post-Infection Therapeutic Drugs Market – 2020-2024
2.1 COVID-19 Post-Infection Therapies Drugs Market Background
2.1.1 Introduction
2.1.2 Computer Aided COVID-19 Drug Research
2.1.3 Adaptive Designs For COVID‑19 Clinical Trials
2.1.4 COVID-19 Therapeutic Drugs Market: Conclusions
2.1.5 COVID-19 Therapeutic Drug :Business Opportunities.
2.1.6 COVID-19 Post-Infection Therapeutic Drug: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
2.1.7 Present and Potential Vendors.
2.2 Global COVID-19 Post-Infection Therapeutic Drugs Market – 2020-202
2.2.1 COVID-19 Post Infection Therapeutic Drugs Market – 2020-2024: Scenario A
2.2.2 Therapeutic Drugs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

3 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024
3.1 Other COVID-19 Pharma Industry Products Market Background
3.1.1 Introduction and Findings
3.1.2 Other COVID-19 Pharma Industry Products Market: Conclusions.
3.1.3 Other COVID-19 Pharma Industry Products: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
3.2 Global COVID-19 Pandemic Mitigation: Other Pharma Industry Products Market – 2020-2024
3.2.1 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
3.2.2 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

4 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024
4.1 COVID-19 PCR Instrumentation & Software Market Background
4.1.1 Introduction
4.1.2 PCR Technologies & Procedures
4.1.3 PCR Advantages
4.1.4 PCR Limitations.
4.1.5 PCR Based Coronavirus Diagnostics Used and Developed During January – April 2020
4.1.6 Efforts to Develop and Disseminate a Test for COVID-19
4.1.7 PCR Purchasing Considerations.
4.1.8 Costs of PCR Testing
4.1.9 PCR Instrumentation & Software Market: Conclusions
4.1.10 PCR Instrumentation & Software: Business Opportunities
4.1.11 PCR Instrumentation & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution.
4.1.12 Key Vendors
4.2 Global COVID-19 Pandemic Mitigation: PCR Instrumentation & Software Market – 2020-2024
4.2.1 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
4.2.2 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

5 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024
5.1 COVID-19 Robotic PCR Systems & Software Market Background
5.1.1 Introduction and Findings
5.1.2 Pooling PCR Method Testing Over 60 Samples Simultaneously
5.1.3 Robotic PCR Systems & Software Market: Conclusions
5.1.4 Robotic PCR Systems & Software: Business Opportunities
5.1.5 Robotic PCR Systems & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
5.2 Global COVID-19 Pandemic Mitigation: Robotic PCR Systems & Software Market – 2020-2024
5.2.1 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
5.2.2 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

6 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024
6.1 COVID-19 PCR Reagents & Consumables Market Background
6.1.1 Introduction
6.1.2 PCR Reagents & Consumables Market: Conclusions
6.1.3 PCR Reagents & Consumables: Business Opportunities
6.1.4 PCR Reagents & Consumables: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
6.2 1.2 Global COVID-19 Pandemic Mitigation: PCR Reagents & Consumables Market – 2020-2024
6.2.1 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
6.2.2 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

7 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024.
7.1 COVID-19 Nose & Mouth Swabs Market Background
7.1.1 Introduction and Findings
7.1.2 Nose & Mouth Swabs: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
7.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Market – 2020-2024
7.2.1 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
7.2.2 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

8 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024
8.1 COVID-19 Self-collection PCR Test Kits Market Background
8.1.1 Saliva Tests
8.2 COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Market – 2020-2024
8.2.1 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
8.2.2 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

9 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024.
9.1 COVID-19 Serologic Test Kits Market Background
9.1.1 Introduction and Findings
9.1.2 FDA Statement Related to the Status of Serological (Antibody) Tests
9.1.3 Coronavirus Antibody Test Kits
9.1.4 Serologic Test Kits Market: Conclusions
9.1.5 Serologic Test Kits: Business Opportunities
9.1.6 Serologic Test Kits: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
9.1.7 Key Vendors.
9.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Market – 2020-2024
9.2.1 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
9.2.2 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

10 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024.
10.1 COVID-19 Standoff Thermometry Market Background
10.1.1 Introduction and Findings
10.1.2 Standoff Thermometry Market: Conclusions
10.1.3 Standoff Thermometry: Business Opportunities
10.1.4 Key Vendors.
10.2 Global COVID-19 Pandemic Mitigation: Standoff Thermometry Market – 2020-2024
10.2.1 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
10.2.2 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

11 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024.
11.1 COVID-19 X-Ray Procedures Market Background
11.1.1 Introduction and Findings
11.1.2 X-Ray Procedures Market: Conclusions
11.1.3 Key Vendors.
11.2 Global COVID-19 Pandemic Mitigation: X-Ray Procedures Market – 2020-2024.
11.2.1 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
11.2.2 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

12 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024.
12.1 COVID-19 CT Procedures Market Background
12.1.1 Introduction and Findings
12.1.2 CT Procedures Market: Conclusions
12.1.3 CT Procedures: Business Opportunities
12.1.4 Key Vendors.
12.2 Global COVID-19 Pandemic Mitigation: CT Procedures Market – 2020-2024
12.2.1 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
12.2.2 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

13 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024.
13.1 COVID-19 Ultrasound Procedures Market Background
13.1.1 Introduction and Findings
13.1.2 FDA Approved “ EMT & Field” Smartphone-Tablet Based Coronavirus Chest Ultrasound
13.1.3 COVID-19 Chest Ultrasound Diagnostics
13.1.4 Ultrasound Procedures Market: Conclusions
13.1.5 Ultrasound Procedures: Business Opportunities
13.1.6 Key Vendors.
13.2 Global COVID-19 Pandemic Mitigation: Ultrasound Procedures Market – 2020-2024
13.2.1 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
13.2.2 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

14 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024
14.1 COVID-19 FDG-PET/CT Procedures & Wastewater Testing Market Background
14.1.1 Introduction and Findings
14.1.2 FDG-PET/CT Procedures
14.1.3 COVID-19 Wastewater Testing
14.1.4 FDG-PET/CT Procedures & Wastewater Testing Market: Conclusions
14.1.5 FDG-PET/CT Procedures & Wastewater Testing: Business Opportunities
14.1.6 Key Vendors.
14.2 Global COVID-19 Pandemic Mitigation: FDG-PET/CT Procedures & Wastewater Testing Market – 2020-2024
14.2.1 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
14.2.2 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

15 PACS & Teleradiology COVID-19 Pandemic Mitigation Market – 2020-2024.
15.1 PACS & Teleradiology Market Background
15.1.1 Introduction and Findings
15.1.2 The FDA PACS & Teleradiography COVID-19 Pandemic Policy.
15.1.3 PACS & Teleradiology Market: Conclusions
15.1.4 PACS & Teleradiology: Business Opportunities
15.1.5 Key Vendors.
15.2 Global COVID-19 Pandemic Mitigation: PACS & TeleradiologyMarket – 2020-2024
15.2.1 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
15.2.2 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

16 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024
16.1 Pandemic PPE Gowns Market Background
16.1.1 Introduction and Findings
16.1.2 PPE Gowns Market: Conclusions
16.1.3 PPE Gowns: Business Opportunities
16.2 Global COVID-19 Pandemic Mitigation: PPE Gowns Market – 2020-2024
16.2.1 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
16.2.2 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

17 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024
17.1 COVID-19 Gloves Market Background
17.1.1 Introduction and Findings
17.1.2 Gloves Market: Conclusions
17.1.3 Gloves: Business Opportunities.
17.2 Global COVID-19 Pandemic Mitigation: Gloves Market – 2020-2024
17.2.1 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
17.2.2 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

18 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024
18.1 Medical Face Masks Market Background
18.1.1 Introduction and Findings
18.1.2 N95 Masks Vs. Surgical Mask
18.1.3 Face Masks Precautions.
18.1.4 Face Masks Market: Conclusions
18.1.5 Face Masks: Business Opportunities
18.1.6 Key Vendors.
18.2 Global COVID-19 Pandemic Mitigation: Face Masks Market – 2020-2024
18.2.1 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
18.2.2 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

19 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024.
19.1 Medical Face Shields Market Background
19.1.1 Introduction and Findings
19.1.2 Face Shields Standards
19.2 Global COVID-19 Pandemic Mitigation: Medical Face Shields Market – 2020-2024
19.2.1 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
19.2.2 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

20 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024.
20.1 Pandemic Eye Protection Market Background
20.1.1 Introduction and Findings
20.1.2 Key Vendors.
20.2 Global COVID-19 Pandemic Mitigation: Eye Protection Market – 2020-2024.
20.2.1 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
20.2.2 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

21 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024
21.1 Global COVID-19 Pandemic Mitigation: PPE Sterilization: Systems & Consumables Market – 2020-2024
21.1.1 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
21.1.2 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

22 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024
22.1 Hand & Surface Sanitizers Market Background
22.2 Global COVID-19 Pandemic Mitigation: Hand & Surface Sanitizers Market – 2020-2024
22.2.1 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
22.2.2 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

23 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024.
23.1 Decontamination Market Background.
23.1.1 Introduction
23.1.2 Definitions
23.1.3 Timing and Location Of Cleaning And Disinfection Of Surfaces
23.1.4 Hard (Non-porous) Surfaces
23.1.5 Soft (Porous) Surfaces.
23.1.6 Electronics.
23.1.7 Linens, Clothing, and Other Items That Go in the Laundry.
23.1.8 Risk of Exposure.
23.1.9 Considerations for Employers.
23.1.10 Decontamination Market: Conclusions
23.2 Global COVID-19 Pandemic Mitigation: Decontamination Market – 2020-2024
23.2.1 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
23.2.2 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

24 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024
24.1 Global COVID-19 Pandemic Mitigation: Other Personal Protection Gear Market – 2020-2024
24.1.1 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
24.1.2 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

25 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024
25.1 Pandemic AI, Big Data & Deep Learning Market Background
25.1.1 Introduction and Findings
25.1.2 AI Based Early Warnings and Alerts
25.1.3 Tracking and Prediction
25.1.4 Data Dashboards
25.1.5 Diagnosis and Prognosis.
25.1.6 COVID-19 Treatments Optimization
25.1.7 COVID-19 Pandemic Social Control
25.1.8 Pandemic Outbreak Forecasting
25.1.9 AI, Big-Data and Deep Learning Assisted CT Imaging.
25.1.10 AI, Big-Data and Deep-Learning Assisted COVID-19 Treatment
25.1.11 COVID-19: AI Assisted X-rays Imaging
25.1.12 COVID-19 AI, Big Data & Deep Learning.
25.1.13 AI Assisted Pandemic Symptoms Analysis
25.1.14 AI, Big Data & Deep Learning Market: Conclusions
25.1.15 AI, Big Data & Deep Learning: Business Opportunities
25.1.16 Key Vendors.
25.2 Global COVID-19 Pandemic Mitigation: AI, Big Data & Deep Learning Market – 2020-2024
25.2.1 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
25.2.2 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

26 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024
26.1 Pandemic Homecare IT Market Background
26.1.1 Introduction and Findings
26.1.2 Homecare IT Market: Conclusions
26.1.3 Homecare IT: Business Opportunities
26.1.4 Key Vendors.
26.2 Global COVID-19 Pandemic Mitigation: Homecare IT Market – 2020-2024
26.2.1 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
26.2.2 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

27 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024
27.1 Pandemic Geo-Surveillance Systems & Services Market Background.
27.1.1 Introduction and Findings
27.1.2 MIT “Private Kit”
27.1.3 The UK NHS COVID-19 App
27.1.4 Companies Making Cell Location Tracking Technology.
27.2 Global COVID-19 Pandemic Mitigation: Geo-Surveillance Systems & Services Market – 2020-2024
27.2.1 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
27.2.2 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

28 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024
28.1 Pandemic E-Health Market Background
28.1.1 Introduction and Findings
28.1.2 E-Health Market: Conclusions
28.1.3 E-Health: Business Opportunities.
28.1.4 Key Vendors.
28.2 Global COVID-19 Pandemic Mitigation: E-Health Market – 2020-2024
28.2.1 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
28.2.2 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

29 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024
29.1 Pandemic Blockchain Technologies Market Background
29.1.1 Introduction and Findings
29.1.2 Blockchain in Healthcare.
29.1.3 Blockchain Applications
29.1.4 Blockchain Technologies Market: Conclusions
29.1.5 Blockchain Technologies: Business Opportunities
29.1.6 Key Vendors.
29.2 Global COVID-19 Pandemic Mitigation: Blockchain Technologies Market – 2020-2024
29.2.1 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
29.2.2 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

30 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024
30.1 Other Pandemics ICT Market Background
30.1.1 Introduction and Findings
30.1.2 Other ICT Market: Conclusions.
30.1.3 Other ICT: Business Opportunities
30.1.4 Vendors
30.2 Global COVID-19 Pandemic Mitigation: Other ICT Market – 2020-2024
30.2.1 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
30.2.2 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

31 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024
31.1 Non-Invasive Ventilators Market Background
31.1.1 Introduction and Findings
31.1.2 The U.S. HHS Procurement Contracts On Non-Invasive Ventilators With Ten Vendors.
31.1.3 Helmet-Based Non-invasive Ventilators.
31.1.4 Non-invasive Ventilators Market: Conclusions
31.1.5 Business Opportunities
31.1.6 Non-invasive Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
31.1.7 Key Vendors.
31.2 Global COVID-19 Pandemic Mitigation: Noninvasive Ventilators Market – 2020-2024
31.2.1 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
31.2.2 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

32 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024
32.1 Invasive Mechanical Ventilators Market Background
32.1.1 Introduction and Findings
32.1.2 Challenges of Traditional Mechanical Ventilation Devices.
32.1.2.1 Difficult To Expand Capacity And Limited Portability
32.1.2.2 Complex and Time Consuming To Administer Care
32.1.2.3 Difficult To Switch Between Therapies
32.1.3 Invasive Mechanical Ventilators Market: Conclusions
32.1.4 Invasive Mechanical Ventilators: Business Opportunities
32.1.5 Invasive Mechanical Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution.
32.1.6 Key Vendors.
32.2 Global COVID-19 Pandemic Mitigation: Invasive Mechanical Ventilators Market – 2020-2024
32.2.1 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
32.2.2 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

33 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024
33.1 Next Generation Ventilators Market Background
33.1.1 Introduction and Findings
33.1.2 Next Generation Ventilators Market: Conclusions
33.1.3 Next Generation Ventilators: Business Opportunities
33.1.4 Next Generation Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution.
33.2 Global COVID-19 Pandemic Mitigation: Next Generation Ventilators Market – 2020-2024
33.2.1 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
33.2.2 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

34 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024
34.1 COVID-19 Homecare “ICU” (Equipment, Software, Services) Market Background
34.1.1 Introduction and Findings
34.1.2 WHO Protocol For COVID-19 Homecare
34.1.3 Homecare Market: Conclusions.
34.1.4 Homecare Business Opportunities
34.1.5 Homecare: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
34.1.6 Key Vendors.
34.2 Global COVID-19 Pandemic Mitigation: Homecare “ICU” (Equipment, Software, Services) Market – 2020-2024
34.2.1 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
34.2.2 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B
34.3 Portable Ventilators Market Background
34.3.1 Introduction and Findings
34.3.2 Portable Ventilators Market: Conclusions
34.3.3 Key Vendors.
34.4 Global COVID-19 Pandemic Mitigation: Mobile Ventilators Market – 2020-2024
34.4.1 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
34.4.2 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

35 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024
35.1 Surge Capacity Hospitals Market Background
35.1.1 Introduction and Findings
35.1.2 Surge Capacity Hospitals Market: Conclusions
35.2 Global COVID-19 Pandemic Mitigation: Surge Capacity Hospitals Market – 2020-2024
35.2.1 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
35.2.2 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

36 Kidney Dialysis COVID-19 Pandemic Mitigation Market – 2020-2024.
36.1 Kidney Dialysis Systems Market Background
36.1.1 Introduction and Findings
36.1.2 Kidney Dialysis Systems Market: Conclusions
36.1.3 Kidney Dialysis Systems: Business Opportunities
36.1.4 Key Vendors.
36.2 Global COVID-19 Pandemic Mitigation: Kidney Dialysis Market – 2020-2024
36.2.1 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
36.2.2 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

37 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024
37.1 Extracorporeal Membrane Oxygenation Procedures Market Background.
37.1.1 Introduction and Findings
37.1.2 The FDA Extracorporeal Membrane Oxygenation (ECMO) Policy
37.1.3 Extracorporeal Membrane Oxygenation Procedures Market: Conclusions
37.1.4 Extracorporeal Membrane Oxygenation Procedures: Business Opportunities
37.1.5 Key Vendors.
37.2 Global COVID-19 Pandemic Mitigation: Extracorporeal Membrane Oxygenation Procedures Market – 2020-2024
37.2.1 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
37.2.2 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

38 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024
38.1 Other Intensive Care Modalities Market Background
38.1.1 Introduction and Findings
38.1.2 Other Intensive Care Modalities Market: Conclusions
38.2 Global COVID-19 Pandemic Mitigation: Other Intensive Care Modalities Market – 2020-2024
38.2.1 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
38.2.2 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

39 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
39.1 PPE Gowns Manufacturing Plants Market Background
39.1.1 Introduction and Findings
39.1.2 Gowns Manufacturing Plants Market: Conclusions
39.1.3 Gowns Manufacturing Plants: Business Opportunities
39.2 Global COVID-19 Pandemic Mitigation: Gowns Manufacturing Plants Market – 2020-2024
39.2.1 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
39.2.2 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

40 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
40.1 Medical PPE Gloves Manufacturing Plants Market Background
40.1.1 Introduction and Findings
40.1.2 Medical PPE Gloves Manufacturing Plants Market: Conclusions
40.1.3 Medical PPE Gloves Manufacturing Plants: Business Opportunities
40.2 Global COVID-19 Pandemic Mitigation: Gloves Manufacturing Plants Market – 2020-2024
40.2.1 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
40.2.2 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

41 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
41.1 Face Masks Manufacturing Plants Market Background
41.1.1 Introduction and Findings
41.1.2 N95 Respirators Manufacturing.
41.1.3 Face Masks Manufacturing Plants Market: Conclusions
41.1.4 Face Masks Manufacturing Plants: Business Opportunities
41.1.5 Key Vendors.
41.2 Global COVID-19 Pandemic Mitigation: Face Masks Manufacturing Plants Market – 2020-2024
41.2.1 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
41.2.2 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

42 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
42.1 Face Shields Manufacturing Plants Market Background
42.1.1 Introduction and Findings
42.2 Global COVID-19 Pandemic Mitigation: Face Shields Manufacturing Plants Market – 2020-2024
42.2.1 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
42.2.2 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

43 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
43.1 Serologic Test Kits Manufacturing Plants Market Background
43.1.1 Introduction and Findings
43.1.2 Serologic Test Kits Manufacturing Plants Market: Conclusions
43.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Manufacturing Plants Market – 2020-2024
43.2.1 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
43.2.2 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

44 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
44.1 Melt-Blown PPE Fabric Manufacturing Plants Market Background
44.1.1 Introduction and Findings
44.1.2 Melt-Blown PPE Fabric. Manufacturing Plants Market: Conclusions
44.2 Global COVID-19 Pandemic Mitigation: Melt-Blown PPE Fabric Manufacturing Plants Market – 2020-2024.
44.2.1 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
44.2.2 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

45 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
45.1 Spun-Bond PPE Fabric Manufacturing Plants Market Background
45.1.1 Introduction and Findings
45.1.2 Spun-Bond PPE Fabric Manufacturing Plants Market: Conclusions
45.2 Global COVID-19 Pandemic Mitigation: Spun-Bond PPE Fabric Manufacturing Plants Market – 2020-2024.
45.2.1 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
45.2.2 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

46 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
46.1 Market Background
46.2 Global COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Manufacturing Plants Market – 2020-2024
46.2.1 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
46.2.2 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

47 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
47.1 Ventilators Manufacturing Plants Market Background
47.1.1 Introduction and Findings
47.1.2 Ventilators Manufacturing Plants Market: Conclusions
47.2 Global COVID-19 Pandemic Mitigation: Ventilators Manufacturing Plants Market – 2020-2024
47.2.1 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
47.2.2 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

48 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
48.1 Global COVID-19 Pandemic Mitigation: PCR Reagents Manufacturing Plants Market – 2020-2024
48.1.1 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
48.1.2 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B
49 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
49.1 Global COVID-19 Pandemic Mitigation: PCR Systems Manufacturing Plants Market – 2020-2024
49.1.1 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
49.1.2 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

50 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
50.1 Nose & Mouth Swabs Manufacturing Plants Market Background
50.1.1 Introduction and Findings
50.1.2 Swabs Manufacturing Plants Market: Conclusions
50.1.3 Swabs Manufacturing Plants: Business Opportunities
50.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Manufacturing Plants Market – 2020-2024.
50.2.1 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
50.2.2 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

51 Medical Glass & Other Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
51.1 Global COVID-19 Pandemic Mitigation: Medical Glass & Other Manufacturing Plants Market – 2020-2024.
51.1.1 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
51.1.2 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

52 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024
52.1 Global COVID-19 Pandemic Mitigation: R&D Equipment & Consumables Market – 2020-2024
52.1.1 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
52.1.2 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

53 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024
53.1 Medical Glass and Other Products & Services Market Background.
53.1.1 Medical Glass Introduction and Findings
53.1.2 Medical Glass Market: Conclusions
53.1.3 Key Medical Glass Vendors.
53.2 Global COVID-19 Pandemic Mitigation: Medical Glass and Other Products & Services Market – 2020-2024
53.2.1 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
53.2.2 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 3

1 Hospitals and Surge Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024
1.1 Market Background
1.2 Global COVID-19 Pandemic Mitigation: Hospitals and Surge Hospitals Market – 2020-2024
1.2.1 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario A
1.2.2 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario B
1.2.3 Hospitals and Surge Hospitals Market: Scenarios Comparison

2 Clinical Labs COVID-19 Pandemic Mitigation Market – 2020-2024
2.1 Market Background
2.2 Global COVID-19 Pandemic Mitigation: Clinical Labs Market – 2020-2024
2.2.1 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario A.
2.2.2 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario B.
2.2.3 Clinical Labs Market: Scenarios Comparison.

3 Clinics COVID-19 Pandemic Mitigation Market – 2020-2024
3.1 Market Background
3.2 Global COVID-19 Pandemic Mitigation: Clinics Market – 2020-2024
3.2.1 COVID-19 Pandemic Mitigation Clinics Market: Scenario A
3.2.2 COVID-19 Pandemic Mitigation Clinics Market: Scenario B
3.2.3 Clinics Market: Scenarios Comparison

4 Emergency Medical Services (EMS) COVID-19 Pandemic Mitigation Market – 2020-2020
4.1 Market Background
4.2 Global COVID-19 Pandemic Mitigation: Emergency Medical Services (EMS) Market – 2020-2024.
4.2.1 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario A
4.2.2 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario B
4.2.3 Emergency Medical Services Market: Scenarios Comparison

5 Homecare & Nursing Homes COVID-19 Pandemic Mitigation Market – 2020-2024
5.1 Market Background
5.2 Global COVID-19 Pandemic Mitigation: Homecare & Nursing Homes Market – 2020-2024
5.2.1 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario A
5.2.2 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario B
5.2.3 Homecare & Nursing Homes Market: Scenarios Comparison

6 Research Bodies COVID-19 Pandemic Mitigation Market – 2020-2024
6.1 Market Background
6.2 Global COVID-19 Pandemic Mitigation: Research Bodies Market – 2020-2024
6.2.1 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario A
6.2.2 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario B
6.2.3 Research Bodies Market: Scenarios Comparison.

7 North America COVID-19 Pandemic Mitigation Market – 2020-2024.
7.1 North America Vertical Markets – 2020-2024
7.1.1 North America COVID-19 Pandemic Mitigation Market: Scenario A
7.1.2 North America COVID-19 Pandemic Mitigation Market: Scenario B
7.1.3 Scenarios Comparison
7.2 North America COVID-19 Pandemic Mitigation Market by Revenue Source – 2020-2024
7.2.1 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
7.2.2 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

8 Europe COVID-19 Pandemic Mitigation Market – 2020-2024
8.1 Europe Vertical Markets – 2020-2024
8.1.1 Europe COVID-19 Pandemic Mitigation Market: Scenario A
8.1.2 Europe COVID-19 Pandemic Mitigation Market: Scenario B
8.1.3 Scenarios Comparison
8.2 Europe COVID-19 Market by Revenue Source – 2020-2024.
8.2.1 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
8.2.2 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

9 Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024
9.1 Asia-Pacific Vertical Markets – 2020-2024
9.1.1 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario A
9.1.2 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario B
9.1.3 Scenarios Comparison
9.2 Asia-Pacific COVID-19 Market by Revenue Source – 2020-2024.
9.2.1 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
9.2.2 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

10 MEA & Latin America COVID-19 Pandemic Mitigation Market – 2020-2024.
10.1 MEA & Latin America Vertical Markets – 2020-2024
10.1.1 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario A
10.1.2 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario B
10.1.3 Scenarios Comparison
10.2 MEA & Latin America COVID-19 Market by Revenue Source – 2020-2024
10.2.1 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A.
10.2.2 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B.

11 USA COVID-19 Pandemic Mitigation Market – 2020-2024
11.1 Market Background
11.2 USA COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

12 Canada COVID-19 Pandemic Mitigation Market – 2020-2024
12.1 Market Background
12.2 Canada COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

13 U.K. COVID-19 Pandemic Mitigation Market – 2020-2024
13.1 Market Background
13.2 U.K. COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

14 Germany COVID-19 Pandemic Mitigation Market – 2020-2024
14.1 Market Background
14.2 Germany COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

15 France COVID-19 Pandemic Mitigation Market – 2020-2024
15.1 Market Background
15.2 France COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

16 Italy COVID-19 Pandemic Mitigation Market – 2020-2024
16.1 Market Background
16.2 Italy COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

17 Rest of Europe COVID-19 Pandemic Mitigation Market – 2020-2024.

18 India COVID-19 Pandemic Mitigation Market – 2020-2024
18.1 Market Background
18.2 India COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

19 China COVID-19 Pandemic Mitigation Market – 2020-2024.
19.1 Market Background
19.2 China COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

20 South Korea COVID-19 Pandemic Mitigation Market – 2020-2024.
20.1 Market Background
20.2 South Korea COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

21 Japan COVID-19 Pandemic Mitigation Market – 2020-2024.
21.1 Market Background
21.2 Japan COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

22 Rest of Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024

23 ROW COVID-19 Pandemic Mitigation Market – 2020-2024

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 4

1 Vendor 1
1.1 Company Profile
1.2 2017- 2019 Financials
1.3 COVID-19 Mitigation Activities & Products

2 Vendor 2
2.1 Company Profile
2.2 2017- 2019 Financials.
2.3 COVID-19 Mitigation Activities & Products

3 Vendor 3
3.1 Company Profile
3.2 2017- 2018 Financials.
3.3 COVID-19 Mitigation Activities & Products

4 Vendor 4
4.1 Company Profile
4.2 2017- 2018 Financials.
4.3 COVID-19 Mitigation Activities & Products

5 Vendor 5
5.1 Company Profile
5.2 2017- 2019 Financials.
5.3 COVID-19 Mitigation Activities & Products

6 Vendor 6
6.1 Company Profile
6.2 2017- 2018 Financials.
6.3 COVID-19 Mitigation Activities & Products

7 Vendor 7
7.1 Company Profile
7.2 2017- 2019 Financials.
7.3 COVID-19 Mitigation Activities & Products

8 Vendor 8
8.1 Company Profile
8.2 2017- 2019 Financials.
8.3 COVID-19 Mitigation Activities & Products

9 Vendor 9
9.1 Company Profile
9.2 2017- 2019 Financials.
9.3 COVID-19 Mitigation Activities & Products

10 Vendor 10
10.1 Company Profile
10.2 2017- 2019 Financials.
10.3 COVID-19 Mitigation Activities & Products

11 Vendor 11
11.1 Company Profile
11.2 2017- 2019 Financials.
11.3 COVID-19 Mitigation Activities & Products

12 Vendor 12
12.1 Company Profile
12.2 2017- 2019 Financials.
12.3 COVID-19 Mitigation Activities & Products

13 Vendor 13
13.1 Company Profile
13.2 2017- 2019 Financials.
13.3 COVID-19 Mitigation Activities & Products

14 Vendor 14
14.1 Company Profile
14.2 2017- 2019 Financials.
14.3 COVID-19 Mitigation Activities & Products

15 Vendor 15
15.1 Company Profile
15.2 2017- 2019 Financials.
15.3 COVID-19 Mitigation Activities & Products

16 Vendor 16
16.1 Company Profile
16.2 2017- 2019 Financials.
16.3 COVID-19 Mitigation Activities & Products

17 Vendor 17
17.1 Company Profile
17.2 2017- 2019 Financials.
17.3 COVID-19 Mitigation Activities & Products

18 Vendor 18
18.1 Company Profile
18.2 2017- 2019 Financials.
18.3 COVID-19 Mitigation Activities & Products

19 Vendor 19
19.1 Company Profile
19.2 2017- 2019 Financials.
19.3 COVID-19 Mitigation Activities & Products

20 Vendor 20
20.1 Company Profile
20.2 2016- 2018 Financials.
20.3 COVID-19 Mitigation Activities & Products

21 Vendor 21
21.1 Company Profile
21.2 2017- 2019 Financials.
21.3 COVID-19 Mitigation Activities & Products

22 Vendor 22
22.1 Company Profile
22.2 2017- 2019 Financials.
22.3 COVID-19 Mitigation Activities & Products

23 Vendor 23
23.1 Company Profile
23.2 2017- 2019 Financials.
23.3 COVID-19 Mitigation Activities & Products

24 Vendor 24
24.1 Company Profile
24.2 2017- 2019 Financials.
24.3 COVID-19 Mitigation Activities & Products

25 Vendor 25
25.1 Company Profile
25.2 2017- 2019 Financials.
25.3 COVID-19 Mitigation Activities & Products

26 Vendor 26
26.1 Company Profile
26.2 2017- 2019 Financials.
26.3 COVID-19 Mitigation Activities & Products

27 Vendor 27
27.1 Company Profile
27.2 2017- 2019 Financials.
27.3 COVID-19 Mitigation Activities & Products

28 Vendor 28
28.1 Company Profile
28.2 2017- 2019 Financials.
28.3 COVID-19 Mitigation Activities & Products

29 Vendor 29
29.1 Company Profile
29.2 2017- 2019 Financials.
29.3 COVID-19 Mitigation Activities & Products

30 Vendor 30
30.1 Company Profile
30.2 2017- 2019 Financials.
30.3 COVID-19 Mitigation Activities & Products

31 Vendor 31
31.1 Company Profile
31.2 2017- 2019 Financials.
31.3 COVID-19 Mitigation Activities & Products

32 Vendor 32
32.1 Company Profile
32.2 2017- 2019 Financials.
32.3 COVID-19 Mitigation Activities & Products

33 Vendor 33
33.1 Company Profile
33.2 2017- 2019 Financials.
33.3 COVID-19 Mitigation Activities & Products

34 Vendor 34
34.1 Company Profile
34.2 2008- 2010 Financials.
34.3 COVID-19 Mitigation Activities & Products

35 Vendor 35
35.1 Company Profile
35.2 2017- 2019 Financials.
35.3 COVID-19 Mitigation Activities & Products

36 Vendor 36
36.1 Company Profile
36.2 2017- 2019 Financials.
36.3 COVID-19 Mitigation Activities & Products

37 Vendor 37
37.1 Company Profile
37.2 2013- 2015 Financials.
37.3 COVID-19 Mitigation Activities & Products

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 5

1 Appendix 1: Differences & Similarities Between Common Flu and Coronavirus
1.1 Similarities:
1.2 Differences

2 Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel
2.1 Introduction
2.2 Conclusions
2.3 Findings Summary
2.4 Background
2.4.1 Description of the Condition
2.4.2 Description of the Intervention
2.4.3 How the Intervention Might Work.
2.4.4 Why it Is Important To Do This Review
2.4.5 Summary

3 Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection
3.1 Introduction
3.1.1 Contingency Capacity Strategies.
3.1.2 Extended Use Of Eye Protection.
3.1.3 Crisis Capacity Strategies.
3.1.4 Selected Options for Reprocessing Eye Protection

4 Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns
4.1 Purpose
4.2 Conventional Capacity Strategies
4.3 Contingency Capacity Strategies.
4.4 Crisis Capacity Strategies.
4.5 Extended Use of Isolation Gowns
4.5.1 Re-use of Cloth Isolation Gowns.
4.5.2 Prioritize Gowns.
4.5.3 When No Gowns Are Available

5 Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks.
5.1 Purpose
5.2 Conventional Capacity Strategies
5.3 Contingency Capacity Strategies.
5.4 When No Facemasks Are Available, Options Include

6 Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators

7 Appendix 7: CDC Adult Vaccine Price List
7.1 CDC Vaccine 2020-2021 Price List.
7.2 CDC Influenza Vaccine 2020-2021 Price List

8 Appendix 8: The CDC COVID-19 Bio-Safety Guidelines
8.1 The CDC Safety Practices for Critical Infrastructure Workers Exposed to a Person with Suspected or Confirmed COVID-19
8.2 Use of Cloth Face Coverings
8.3 The Emergency Medical Services Guidance
8.4 Recommendations for 911 PSAPs
8.4.1 Modified Caller Queries
8.5 EMS Clinicians and Medical First Responders
8.5.1 Patient assessment
8.6 Recommended Personal Protective Equipment
8.7 Precautions for Aerosol-Generating Procedures
8.8 EMS Transport of a PUI or Patient with Confirmed COVID-19 to a Healthcare Facility
8.9 Documentation Of Patient Care
8.10 Cleaning EMS Transport Vehicles after Transporting a PUI or Patient with Confirmed COVID-19
8.11 Measures by EMS Clinicians After Caring for a PUI or Patient with Confirmed COVID-19
8.12 EMS Employer Responsibilities

9 Appendix 9: The 2020 Global Desperation to Protect Medical Workers

10 Appendix 10: Disinfection Procedures for COVID-19
10.1 Disinfection for Floor and Walls
10.2 Disinfection of Object Surfaces
10.3 Air Disinfection
10.4 Disposal of Fecal Matter and Sewage
10.5 Disposal Procedures for Spills of COVID-19 Patient Blood/Fluids

11 Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020
11.1 Public Health and Social Services Emergency Fund – March 2020
11.2 For Advance Construction, Manufacture, And Purchase Of Vaccines And Therapeutic Delivery
11.3 Telehealth, Poison Control Centers, And The Ryan White HIV/AIDS Program
11.4 National Institutes of Health
11.5 Substance Abuse and Mental Health Services Administration
11.6 Administration for Children and Families
11.7 Veterans Health Administration

12 Appendix 12: European Preparedness Against Emerging Epidemics.

13 Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19
13.1 Introduction
13.2 Diagnostic Tests
13.1.1 IVD Tests
13.1.2 LDT Tests.
13.1.3 How are IVD Tests Regulated?
13.1.4 How are LDTs Regulated?
13.1.5 What is CLIA and How Is It Involved in LDT Regulation?
13.1.6 How are IVDs Regulated by the FDA During an Emergency Such as the Outbreak of COVID-19?.
13.1.7 How Does the Emergency Use Authority Apply to LDTs if They Are Generally Exempted from Premarket Requirements?
13.1.8 How Does the CDC’s COVID-19 Diagnostic Test Work?
13.1.9 What Type of IVD is the CDC’s Test and Who May Carry it Out?
13.1.10 What Is the Role of the Commercial Manufacturer IDT in the Development and Distribution of the CDC’s Test Kit?
13.1.11 What Quality Problems Did the CDC’s Test Experience on Rollout to the State and Local Public Health Laboratories?
13.1.12 What Steps did the FDA Take to Expand Testing Capacity in Response to the Problems with the CDC’s Test?

14 Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

15 Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)

16 Appendix 16: Comparing Clinical COVID-19 Data by Nation
16.1 Introduction
16.2 Counting Deaths Protocols
16.3 National Death Rates
16.4 National Political Factors
16.5 National Testing Protocols.
16.6 Conclusions: Comparisons are Difficult.

17 Appendix 17: Home Healthcare IT
17.1 Introduction
17.2 Online Bots
17.3 Home Telehealth
17.4 Telemedicine Billing.
17.5 Commercial Insurance

18 Appendix 18: The Difference between PCR and Antibody Tests

19 Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021.
19.1 Introduction
19.2 Economic Effects
19.3 USA
19.4 Europe
19.5 The UK
19.6 Japan
19.7 China
19.8 The IMF
19.9 The World Bank.
19.10 Emerging Markets
19.11 Other Sectors

20 Appendix 20: COVID-19 Tests.
20.1 COVID-19 Tests Sensitivity and Specificity
20.2 RT-PCR tests
20.3 Antibody Tests.
20.4 Other Diagnostic Options
20.5 Procurement of Test Kits and Consumables
20.6 Annex A: Test Kit Options from WHO Diagnostics Consortium

21 Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region

22 Appendix 22: Abbreviations.

23 Appendix 23: Glossary

24 Appendix 24: Bibliography

25 Research Methodology
25.1 Scope
25.2 Research Methodology.

26 Disclaimer & Copyright

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Company
  • 3Scan
  • Abbott
  • AbCellera
  • Advenio Technosys
  • Agfa Healthcare
  • Agilent Technologies
  • AiCure
  • Aindra
  • Allscripts Healthcare Solutions
  • Amara Health Analytics
  • Amazon
  • analyticsMD
  • Apixio
  • Apple
  • Arterys Inc
  • Atlas Wearables
  • Atomwise
  • Avalon Nutrition VITL
  • Babylon Health
  • Bay Labs
  • Behold.ai
  • benevolent.ai
  • BIOBEATS
  • BlueDot
  • Bollé Safety
  • Bullard
  • Buoy Health
  • Care Angel Wearables QorQL
  • Careskore
  • Clinithink
  • Cloud Pharmaceuticals
  • CloudMedx
  • CureMetrix Mental health Ginger.io
  • Cyrcadia
  • Deep 6 AI
  • Deep Genomics
  • Dell Technologies Inc.
  • Delta Plus Group
  • Desktop Genetics Virtual mate Ada Health
  • DreaMed Diabetes
  • Dupont
  • EaglEyeMed
  • Eli Lilly
  • Encon Safety Products
  • Enlitic
  • EnsoData
  • Entopsis
  • Envisagenics Research iCarbonX
  • ERB Industries Inc.
  • Ergodyne
  • Essilor of America
  • Flashback Technologies
  • Flow Health
  • Ford
  • Freenome
  • Frequency Therapeutics Inc.
  • Fujifilm Holdings Corporation
  • Gateway Safety Inc.
  • GE Healthcare
  • General Electric
  • General Motors
  • General Vision
  • Gentex Corporation
  • Gibco
  • Gilead Sciences
  • Globavir Biosciences
  • Google
  • Healint
  • Health Fidelity
  • HealthNextGen
  • HexArmor
  • Hindsait
  • Honeywell Safety Products
  • IBM
  • Imagen Technologies
  • Imagia Cybernetics
  • Infermedica
  • Infervision
  • Inovio Pharmaceuticals
  • Inside DNA
  • InSilico Medicine
  • Intel Corporation
  • Intendu
  • Invitrogen
  • Ion Torrent
  • Ironwear
  • Johnson & Johnson (Janssen)
  • Jvion
  • Kapa Biosystems
  • Keen Eye Technologies
  • Kimberly-Clark Professional
  • Koninklijke Philips NV
  • Lexmark International Inc.
  • LifeGraph
  • Lucina Health
  • Lumiata
  • Lunit
  • Lytics
  • Magnea
  • Maxim Biotech
  • Maxwell MRI
  • McKesson Corporation
  • MCR Safety
  • Medal
  • Medalogix
  • Medasense
  • MedAware
  • Medtronic
  • MedWhat
  • MedyMatch
  • Merck
  • Metabiota
  • Micron Technology
  • Microsoft Corporation
  • Mindshare Medical
  • Moderna
  • Morpheo
  • Niramai Health Analytix
  • Novarad Corporation
  • NuMedii
  • Numerate
  • Nuritas Pharma Turbine
  • Nvidia Corporation
  • Oncora Medical
  • Ovuline
  • PeerWell
  • Pfizer
  • Philips
  • Philips Healthcare
  • PhysIQ.
  • Precision Health Intelligence
  • Predible Health
  • Profility
  • Proscia
  • pulseData
  • Pyramex Safety
  • Qualaris Healthcare Solutions
  • Qualcomm Incorporated
  • Qualcomm Incorporated
  • Qure. Ai
  • Radians Inc.
  • Recursion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Roam Analytics   
  • Roche
  • RxPREDICT
  • Safety Optical Service
  • Samsung Electronics Co.
  • Ltd
  • Sanofi
  • Saykara
  • Sellstrom Manufacturing Company (SureWerx)
  • Sense.ly
  • Sensory Inc.
  • Siemens
  • Sigma-Aldrich Corp.
  • Skymind Inc.
  • Thermo Fisher Scientific
  • Toshiba
  • Vir Biotechnology Inc.
  • VisionAid Inc.
  • WuXi Biologics
  • Xilinx Inc.
Note: Product cover images may vary from those shown
Adroll
adroll